COVID-19患者接受远程监测的住院结局
这项回顾性观察性队列研究在威斯康星州东南部一家学术健康系统进行,纳入2020年3月30日至2020年12月15日门诊SARS-CoV-2检测阳性的10660例患者,其中9378例受邀加入RPM项目。激活监测的5364例(57.2%)与未激活的4014例相比,加权回归分析显示激活RPM与较低的住院 odds 相关(OR 0.68,95%CI 0.54-0.86,P=.001);激活组住院率2.4% vs 未激活组3.9%(P<.001),且激活组检测至住院时间更长、住院时长更短、ICU使用更少。这些发现提示RPM项目激活可能与COVID-19患者较好的结局相关。
要点
- 在10660例门诊COVID-19患者中,激活RPM与较低的住院 odds 相关(OR 0.68,95%CI 0.54-0.86,P=.001),校正人口学、合并症和时间段。
- 激活RPM组住院128/5364例(2.4%),未激活组住院158/4014例(3.9%),差异有统计学意义(χ21=18.65;P<.001)。
- 激活RPM组检测至住院平均时间6.67天(SD 3.21)vs 未激活组5.24天(SD 3.03),住院时长4.44天(SD 4.43)vs 7.14天(SD 8.63)。
- 激活RPM组ICU使用15例(0.3%)vs 未激活组44例(1.1%)。
- 激活RPM的5364例患者平均签到35.3次(SD 33.0),878例(16.4%)经历至少1次警报。
适用人群与场景
- 在门诊环境中SARS-CoV-2检测阳性、且有内部初级保健医生的患者,年龄均值46.9岁(SD 16.3),女性5448例(58.1%)。
- 研究时段为2020年3月30日至2020年12月15日,地点为威斯康星州东南部Froedtert & Medical College of Wisconsin Health Network学术健康系统。
研究设计与关键结果
- 研究类型:回顾性观察性队列研究;纳入10660例符合条件的COVID-19阳性门诊患者,其中9378例(88.0%)有电子邮件或手机号码并受邀加入RPM项目。
- 暴露:激活RPM项目;主要结局:检测阳性后2至14天内住院;采用逆倾向评分加权校正组间差异。
- 激活RPM的5364例(57.2%)平均签到35.3次(SD 33.0),平均自由文本评论1.27条(SD 2.79;中位数[IQR] 0[0-1]);878例(16.4%)经历至少1次警报。
- 住院:激活组128/5364例(2.4%)vs 未激活组158/4014例(3.9%),χ21=18.65;P<.001。
- 加权回归分析:激活RPM与较低的住院 odds 相关(OR 0.68;95%CI 0.54-0.86;P=.001),校正人口学、合并症和时间段。
- 激活组检测至住院平均时间6.67天(SD 3.21)vs 未激活组5.24天(SD 3.03);住院时长4.44天(SD 4.43)vs 7.14天(SD 8.63);ICU使用15例(0.3%)vs 44例(1.1%)。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究;原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,激活RPM项目与COVID-19患者较低的住院、ICU使用和住院时长相关;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Health care systems have implemented remote patient monitoring (RPM) programs to manage patients with COVID-19 at home, but the associations between participation and outcomes or resource utilization are unclear.
OBJECTIVE: To assess whether an RPM program for COVID-19 is associated with lower or higher likelihood of hospitalization and whether patients who are admitted present earlier or later for hospital care.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective, observational, cohort study of RPM was performed at Froedtert & Medical College of Wisconsin Health Network, an academic health system in southeastern Wisconsin. Participants included patients with internal primary care physicians and a positive SARS-CoV-2 test in the ambulatory setting between March 30, 2020, and December 15, 2020. Data analysis was performed from February 15, 2021, to February 2, 2022.
EXPOSURES: Activation of RPM program.
MAIN OUTCOMES AND MEASURES: Hospitalizations within 2 to 14 days of a positive test. Inverse propensity score weighting was used to account for differences between groups. Sensitivity analyses were performed looking at usage of the RPM among patients who activated the program.
RESULTS: A total of 10 660 COVID-19-positive ambulatory patients were eligible, and 9378 (88.0%) had email or mobile numbers on file and were invited into the RPM program; the mean (SD) age was 46.9 (16.3) years and 5448 patients (58.1%) were women. Patients who activated monitoring (5364 patients [57.2%]) had a mean (SD) of 35.3 (33.0) check-ins and a mean (SD) of 1.27 (2.79) (median [IQR], 0 [0-1]) free-text comments. A total of 878 patients (16.4%) experienced at least 1 alert; 128 of 5364 activated patients (2.4%) and 158 of 4014 inactivated patients (3.9%) were hospitalized (χ21 = 18.65; P < .001). In weighted regression analysis, activation of RPM was associated with a lower odds of hospitalization (odds ratio, 0.68; 95% CI, 0.54-0.86; P = .001) adjusted for demographics, comorbidities, and time period. Monitored patients had a longer mean (SD) time between test and hospitalization (6.67 [3.21] days vs 5.24 [3.03] days), a shorter length of stay (4.44 [4.43] days vs 7.14 [8.63] days), and less intensive care use (15 patients [0.3%] vs 44 patients [1.1%]).
CONCLUSIONS AND RELEVANCE: These findings suggest that activation of an RPM program is associated with lower hospitalization, intensive care use, and length of stay among patients with COVID-19.
参考来源
- Crotty BH, Dong Y, Laud P, et al. Hospitalization Outcomes Among Patients With COVID-19 Undergoing Remote Monitoring. JAMA Netw Open. 2022. PMID: 35797044. doi:10.1001/jamanetworkopen.2022.21050
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。